Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population

被引:0
|
作者
Bozina, N
Granic, P
Lalic, Z
Tramisak, I
Lovric, M
Stavljenic-Rukavina, A
机构
[1] Univ Zagreb, Ctr Hosp, Univ Inst Lab Diag, Zagreb 10000, Croatia
[2] Sch Med, Zagreb, Croatia
关键词
alleles; Croatia; cytochrome P450 enzyme system; genotype; phenotype; polymorphism (genetics);
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To determine the prevalence of most common mutations of cytochrome P450 (CYP), ie, allelic variants of CYP2C9, CYP2C19, and CYP2D6, and to predict genotype frequency in the Croatian population. Methods. CYP genotype was determined in 200 non-related Croatian citizens. DNA isolated from blood samples was used for the analysis of the most common allelic variants of CYP2C9, CYP2C19, and CYP2D6 by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results. For 200 subjects genotyped for CYP2C9, the allele frequencies of CYP2C9*1 (wt), CYP2C9*2, and CYP2C9*3 were 0.74 0.165 and 0.095, respectively. Among them, 3.5% of subjects were predicted to be poor metabolizers. For CYP2C19, the most frequent alleles were CYP2C19*1 and CYP2C19*2, with frequencies of 0.85 and 0.15 respectively; 3% of subjects were predicted to be poor metabolizers. For CYP2D6, the most frequent alleles were CYP2D6*1 (frequency 0.765), CYP2D62* (0.04), CYP2D6*3 (0.0275), CYP2D6*4 (0.14), CYP2D6*5 (0.01), and CYP2D6*6 (0.015). Out of these, 3% were predicted to be poor metabolizers, and 4% were predicted to be ultra-rapid metabolizers. Conclusion. The prevalence of allelic variants and predicted genotypes in the Croatian population is in accordance with the other European populations, and it can be interpolated between the values for mid-European and Mediterranean populations.
引用
收藏
页码:425 / 428
页数:4
相关论文
共 50 条
  • [21] The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses
    Kee, Ping Siu
    Maggo, Simran D. S.
    Kennedy, Martin A.
    Chin, Paul K. L.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [22] Genetic contribution of CYP2C9, CYP2C19, and APOE variants in acenocoumarol response
    Nastasi-Catanese, J. A.
    Padilla-Gutierrez, J. R.
    Valle, Y.
    Ortega-Gutierrez, F.
    Gallegos-Arreola, M. P.
    Figuera, L. E.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (04) : 4413 - 4421
  • [23] Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes
    Villagra, David
    Goethe, John
    Schwartz, Harold I.
    Szarek, Bonnie
    Kocherla, Mohan
    Gorowski, Krystyna
    Windemuth, Andreas
    Ruano, Gualberto
    BIOMARKERS IN MEDICINE, 2011, 5 (04) : 427 - 438
  • [24] Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital
    Ruano, Gualberto
    Villagra, David
    Rahim, Umme Salma
    Windemuth, Andreas
    Kocherla, Mohan
    Bower, Bruce
    Szarek, Bonnie L.
    Goethe, John W.
    PERSONALIZED MEDICINE, 2008, 5 (06) : 579 - 587
  • [25] The pharmacokinetics of ketobemidone are not affected by CYP2D6 or CYP2C19 phenotype
    Al-Shurbaji, A
    Säwe, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 57 (12) : 877 - 881
  • [26] Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response
    Atasayar, Gulfer
    Eryilmaz, Isil Ezgi
    Karli, Necdet
    Egeli, Unal
    Zarifoglu, Mehmet
    Cecener, Gulsah
    Taskapilioglu, Ozlern
    Tunca, Berrin
    Yildirim, Oznur
    Ak, Secil
    Tezcan, Gulcin
    Can, Fatma Ezgi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 366 : 149 - 154
  • [27] Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population
    Yousef, Al-Motassem
    Bulatova, Nailya R.
    Newman, William
    Hakooz, Nancy
    Ismail, Said
    Qusa, Hisham
    Zahran, Farah
    Ababneh, Nidaa Anwar
    Hasan, Farah
    Zaloom, Imad
    Khayat, Ghada
    Al-Zmili, Rawan
    Naffa, Randa
    Al-Diab, Ola
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (10) : 9423 - 9433
  • [28] Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population
    Al-Motassem Yousef
    Nailya R. Bulatova
    William Newman
    Nancy Hakooz
    Said Ismail
    Hisham Qusa
    Farah Zahran
    Nidaa Anwar Ababneh
    Farah Hasan
    Imad Zaloom
    Ghada Khayat
    Rawan Al-Zmili
    Randa Naffa
    Ola Al-Diab
    Molecular Biology Reports, 2012, 39 : 9423 - 9433
  • [29] Afro-Latin American Pharmacogenetics of CYP2D6, CYP2C9, and CYP2C19 in Dominicans: A Study from the RIBEF-CEIBA Consortium
    Guevara, Mariela
    Rodrigues-Soares, Fernanda
    de la Cruz, Carla Gonzalez
    de Andres, Fernando
    Rodriguez, Ernesto
    Penas-Lledo, Eva
    Llerena, Adrian
    PHARMACEUTICS, 2024, 16 (11)
  • [30] CYP2C9 genetic polymorphisms and warfarin
    Redman, AR
    Dickmann, LJ
    Kidd, RS
    Goldstein, JA
    Ritchie, DM
    Hon, YY
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2004, 10 (02) : 149 - 154